Transitional Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Transitional Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma [Phase 2]
Phase 2 trial evaluating first-line everolimus with or without paclitaxel in cisplatin-ineligible advanced urothelial carcinoma was terminat…
-
CLINICAL_TRIALS trial_result · 2022-10-05Clinical Trial Update: Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel and pembrolizumab in refractory metastatic urothelial cancer (transitional cell carcinoma) has completed…
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma [Phase 2]
Phase 2 trial of nab-paclitaxel plus gemcitabine as first-line therapy for cisplatin-ineligible or cisplatin-incurable advanced urothelial c…
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma [Phase 2]
Phase 2 trial evaluating a tailored immunotherapy approach with nivolumab in metastatic or advanced transitional cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas [Phase 1]
Phase 1 trial update of a vaccine therapy in transitional cell carcinoma was completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Preoperative Bintrafusp Alfa in Operable Urothelial Carcinoma of the Bladder [Phase 2]
A Phase 2 clinical trial update evaluating preoperative Bintrafusp Alfa in operable urothelial carcinoma of the bladder is in progress.
-
CLINICAL_TRIALS trial_result · 2019-04-11Clinical Trial Update: Alisertib in Chemotherapy-pretreated Urothelial Cancer [Phase 2]
Phase 2 trial of alisertib in chemotherapy-pretreated urothelial/bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-04Clinical Trial Update: Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel [Phase 2, Phase 3]
A completed clinical trial update evaluating cabazitaxel for locally advanced or metastatic transitional cell carcinoma across Phase 2 and P…
-
CLINICAL_TRIALS trial_result · 2017-09-28Clinical Trial Update: Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma [Phase 3]
A Phase 3 trial comparing four vs six cycles of cisplatin-based chemotherapy in metastatic urothelial carcinoma is ongoing/unknown status.
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Dual Energy CT vs Standard Triple Phase CT-A Randomised Control Trial [NA]
This entry notes a completed randomized trial comparing Dual Energy CT to Standard Triple Phase CT Angiography. The study involved patients …
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen [Phase 1]
Phase 1 study of a mixed bacteria vaccine (MBV) targeting NY-ESO-1 tissue expression in various tumors; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types [Phase 2]
Phase II clinical trial of Brivanib (BMS-582664) across multiple tumor types has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-22Clinical Trial Update: Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder [Phase 3]
A Phase 3 trial evaluating maintenance valrubicin versus no maintenance after valrubicin induction in bladder carcinoma in situ; study termi…
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC [Phase 2]
Phase 2 randomized study assessing docetaxel with or without vandetanib in metastatic transitional cell carcinoma of the bladder; study comp…
-
CLINICAL_TRIALS trial_result · 2012-01-24Clinical Trial Update: A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of Chemotherapy [Phase 2]
A single-arm, multicenter Phase II trial evaluating RAD001 (everolimus) as monotherapy for transitional cell carcinoma after chemotherapy fa…
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium [Phase 2]
Phase 2 trial evaluating vinflunine in locally advanced or metastatic urothelial carcinoma of the urothelium (bladder cancer); the study has…
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Relationship of Ochratoxin A to Upper Urologic Cancers
A completed clinical trial examined the relationship between Ochratoxin A exposure and upper urinary tract cancers, including transitional c…
-
CLINICAL_TRIALS trial_result · 2007-07-25Clinical Trial Update: Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC [Phase 2]
A Phase 2 study evaluating gemcitabine combined with ifosfamide as second-line chemotherapy for cisplatin-failed advanced transitional cell …